Correlation Between Black Diamond and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Black Diamond and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Black Diamond Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Black Diamond and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Mineralys Therapeutics,.
Diversification Opportunities for Black Diamond and Mineralys Therapeutics,
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Black and Mineralys is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Black Diamond i.e., Black Diamond and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Black Diamond and Mineralys Therapeutics,
Given the investment horizon of 90 days Black Diamond Therapeutics is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Black Diamond Therapeutics is 1.23 times less risky than Mineralys Therapeutics,. The stock trades about -0.14 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 1,389 in Mineralys Therapeutics, Common on August 28, 2024 and sell it today you would lose (119.00) from holding Mineralys Therapeutics, Common or give up 8.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Black Diamond Therapeutics vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Black Diamond Therap |
| Mineralys Therapeutics, |
Black Diamond and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Black Diamond and Mineralys Therapeutics,
The main advantage of trading using opposite Black Diamond and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Black Diamond vs. Passage Bio | Black Diamond vs. Alector | Black Diamond vs. Revolution Medicines | Black Diamond vs. Stoke Therapeutics |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |